Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1 Mutant Breast Cancer

By
Emily Salmini
-
0
33
The authors identified enrichment of dysregulated replication stress and DNA damage responses in multiple ESR1 mutant models.
[Cancer Research]
Abstract